Scott Biller, Chief Scientific Officer at AGIOS PHARMACEUTICALS INC (AGIO), sold 5,900 shares at $82.52 ($490K) on 2018-09-05, disclosed to the SEC on 2018-09-07.
Open-market sale of $490k AGIO by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.52 | 640 | $53K | 10.8% |
| 2 | $82.52 | 640 | $53K | 10.8% |
| 3 | $83.17 | 2,260 | $188K | 38.4% |
| 4 | $83.17 | 2,260 | $188K | 38.4% |
| 5 | $84.38 | 100 | $8K | 1.7% |
| Total | $83.05 avg | 5,900 |
| $490K |
| 100% |
| Filing → |
| AGIO | SELL | 2019-03-01 | $585K | — | Filing → |
| AGIO | SELL | 2018-11-07 | $209K | — | Filing → |
| AGIO | SELL | 2018-10-09 | $277K | — | Filing → |